Valiant Laboratories IPO details (27 Sep – 3 Oct), (Price ₹133 to ₹140)
Listing date and Listing Price of Valiant Laboratories IPO:
- Valiant Laboratories IPO listed on BSE and NSE exchanges on – Click Here
- Listing Price of Valiant Laboratories IPO on NSE – Click Here
- Listing Price of Valiant Laboratories IPO on BSE – Click Here
Grey Market premium (GMP) price of Valiant Laboratories IPO:
Grey Market premium (GMP) price of Valiant Laboratories IPO is Rs. __. Grey Market premium (GMP) of Valiant Laboratories IPO means, unofficially if someone buys or sells his application at a fixed rate irrespective of listing price. Check latest GMP of all IPOs.
Valiant Laboratories IPO Allotment link status on Link Intime:
- Check the allotment status of Valiant Laboratories IPO on the below link given by Link Intime.
- Valiant Laboratories IPO Allotment Link – https://linkintime.co.in/MIPO/Ipoallotment.html
Valiant Laboratories IPO Allotment link status on Link Intime can be checked by Application No or DP Client ID or PAN.
Valiant Laboratories IPO subscription status details:
| QIB (Qualified Institl. Bidders) | NIB (Non-institutional Investor) | RII (Retail Individual Investor) | Employee category | Total No. of times applied | |
| No. of shares offered | |||||
| Day 1 | |||||
| Day 2 | |||||
| Day 3 |
Valiant Laboratories IPO highlights:
| Valiant Laboratories IPO bid Opens on | 27 Sep 2023 |
| Valiant Laboratories IPO bid Closes on | 02 Oct 2023 |
| Issue type | 100% Book Building |
| Valiant Laboratories IPO issue size | ₹ 152.46 Cr |
| Face value of each equity share | Rs. 10 |
| Valiant Laboratories IPO Price band | Rs 133 to Rs 140 per share |
| Valiant Laboratories IPO market lot | 105 equity shares and multiples |
| Valiant Laboratories IPO minimum order quantity | 105 equity shares |
| Pre IPO equity share of promoters of Valiant Laboratories | 100 % |
| Post IPO paid-up equity share of promoters of Valiant Laboratories | 74.94 % |
| QIB portion reservation in Valiant Laboratories IPO | 50 % |
| NIB portion reservation in Valiant Laboratories IPO | 15 % |
| Retail portion reservation in Valiant Laboratories IPO | 35 % |
| Retail individual bidder can apply in Valiant Laboratories IPO | up to 2 lakh (200,000) – Maximum 13 Lot |
| Retail individual discount in Valiant Laboratories IPO | NA |
| Employees can apply in Valiant Laboratories IPO | NA |
| Employees Reservation in Valiant Laboratories IPO | NA |
| Employees Discount in Valiant Laboratories IPO | NA |
| Listing of Valiant Laboratories at Exchanges | NSE, BSE |
| Fund raised from Anchor Investors in Pre-IPO of Valiant Laboratories | NA |
| Registrar of Valiant Laboratories IPO issue | Link Intime India Private Limited |
Valiant Laboratories IPO important dates regarding bidding, allotment, listing, refund etc. :
The probable dates regarding bidding, allotment, listing, refund of Valiant Laboratories IPO are mentioned below.
| Valiant Laboratories IPO opens on | 27.09.2023 |
| Valiant Laboratories IPO Closes on | 03.10.2023 |
| Allotment basis date of Valiant Laboratories IPO | 05.10.2023 |
| Money refund date of Valiant Laboratories IPO | 06.10.2023 |
| Shares of Valiant Laboratories in Demat Account | 06.10.2023 |
| Valiant Laboratories IPO listing date on NSE, BSE | 09.10.2023 |
How much shares of Valiant Laboratories IPO are being offered?
| Type of Issue (Fresh / OFS) | No. of Equity shares offered | Amount of Equity shares |
| Total Issue size | ₹ 152.46 Crore | |
| Fresh Issue size | – | ₹ 152.46 Crore |
| Offer for Sale (OFS) | – | ₹ 0 Crore |
| Employee Reservation | – | – |
IPO Red Herring Prospectus (RHP) of Valiant Laboratories:
Click here for IPO RHP of Valiant Laboratories on SEBI website.
Business of Valiant Laboratories: (Source – RHP)
We are an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide – C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. We manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of our customers.
Go Back to – IPO Dashboard for other IPOs:
Current and Upcoming main board IPO, IPO Allotment link, IPO listing date, IPO performance
Disclaimer: Kindly verify from RHP and concerned company for any clarification.